
### [MONDO:0010615](http://purl.obolibrary.org/obo/MONDO_0010615)
**Label:** isolated growth hormone deficiency type III

**Subclasses:** [MONDO:0010252](http://purl.obolibrary.org/obo/MONDO_0010252) (mental retardation, X-linked, with panhypopituitarism), [MONDO:0018967](http://purl.obolibrary.org/obo/MONDO_0018967) (short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia), 

**Mapped go classes:** [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0048515](http://purl.obolibrary.org/obo/GO_0048515) (spermatid differentiation), [GO:0060009](http://purl.obolibrary.org/obo/GO_0060009) (Sertoli cell development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0021854](http://purl.obolibrary.org/obo/GO_0021854) (hypothalamus development), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0007423](http://purl.obolibrary.org/obo/GO_0007423) (sensory organ development), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), 

**Class expressions from DL-Learner:**

- [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development) 56.25%
- [GO:0048515](http://purl.obolibrary.org/obo/GO_0048515) (spermatid differentiation) 56.25%
- [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development) 56.25%
- [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development) 56.25%
- [GO:0021854](http://purl.obolibrary.org/obo/GO_0021854) (hypothalamus development) 56.25%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 56.25%
- [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity) 56.25%
- [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity) 56.25%
- [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) 56.25%
- [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity) 56.25%
- [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity) 56.25%
- [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) and [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity) 56.25%
- [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) and [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity) 56.25%
- [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity) and [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity) 56.25%
- [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity) and [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) 56.25%


